[go: up one dir, main page]

WO2002036632A8 - Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides - Google Patents

Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides

Info

Publication number
WO2002036632A8
WO2002036632A8 PCT/US2001/031744 US0131744W WO0236632A8 WO 2002036632 A8 WO2002036632 A8 WO 2002036632A8 US 0131744 W US0131744 W US 0131744W WO 0236632 A8 WO0236632 A8 WO 0236632A8
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
single nucleotide
nucleotide polymorphisms
olfactory receptor
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/031744
Other languages
French (fr)
Other versions
WO2002036632A2 (en
WO2002036632A3 (en
Inventor
John P Ii Alsobrook
Catherine E Burgess
William M Grosse
Denise M Lepley
Muralidhara Padigaru
Kimberly A Spytek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/777,789 external-priority patent/US20030087815A1/en
Application filed by CuraGen Corp filed Critical CuraGen Corp
Priority to AU2001296804A priority Critical patent/AU2001296804A1/en
Publication of WO2002036632A2 publication Critical patent/WO2002036632A2/en
Publication of WO2002036632A8 publication Critical patent/WO2002036632A8/en
Anticipated expiration legal-status Critical
Publication of WO2002036632A3 publication Critical patent/WO2002036632A3/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides novel isolated nucleic acid sequences having single nucleotide polymorphisms that encode olfactory receptor-like polypeptides and the polypeptides so encoded. Also provided are the antibodies that immunospecifically bind to these polypeptides or any derivative, variant, mutant or fragment of the polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
PCT/US2001/031744 2000-11-02 2001-10-09 Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides Ceased WO2002036632A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001296804A AU2001296804A1 (en) 2000-11-02 2001-10-09 Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US24529200P 2000-11-02 2000-11-02
US60/245,292 2000-11-02
US09/777,789 US20030087815A1 (en) 2000-02-07 2001-02-06 Novel polypeptides and nucleic acids encoding same
US09/777,789 2001-02-06
US32375501P 2001-09-20 2001-09-20
US60/323,755 2001-09-20

Publications (3)

Publication Number Publication Date
WO2002036632A2 WO2002036632A2 (en) 2002-05-10
WO2002036632A8 true WO2002036632A8 (en) 2002-09-06
WO2002036632A3 WO2002036632A3 (en) 2003-08-14

Family

ID=27399843

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/031744 Ceased WO2002036632A2 (en) 2000-11-02 2001-10-09 Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides

Country Status (1)

Country Link
WO (1) WO2002036632A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004106935A2 (en) * 2003-05-27 2004-12-09 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 103 (gpr103)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874243A (en) * 1997-03-28 1999-02-23 Smithkline Beecham Corporation OLRCC15 receptor
AU6117699A (en) * 1998-10-14 2000-05-01 Genset Genes encoding olfactory receptors and biallelic markers thereof
WO2001027158A2 (en) * 1999-10-08 2001-04-19 Digiscents Olfactory receptor sequences
EP1252188A2 (en) * 2000-02-02 2002-10-30 Incyte Genomics, Inc. G-protein coupled receptors
US20030087815A1 (en) * 2000-02-07 2003-05-08 Muralidhara Padigaru Novel polypeptides and nucleic acids encoding same
CA2401406A1 (en) * 2000-03-13 2001-09-20 Senomyx, Inc. Human olfactory receptors and genes encoding same
DE60142592D1 (en) * 2000-09-22 2010-08-26 Chemcom Sa G-protein receptors for odor and pheromone molecules

Also Published As

Publication number Publication date
WO2002036632A2 (en) 2002-05-10
WO2002036632A3 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
WO2001092523A3 (en) Human polynucleotides and polypeptides encoded thereby
WO2001007595A3 (en) Novel fibroblast growth factor and nucleic acids encoding same
WO2002057453A3 (en) Polypetides and nucleic acids encoding same
WO2002057450A3 (en) Proteins and nucleic acids encoding same
WO2001036645A3 (en) Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
WO2002098917A3 (en) Human proteins and nucleic acids encoding same
WO2001090155A3 (en) Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
WO2001049729A3 (en) Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use
WO2002066647A3 (en) Type 2 ctokine receptor and nucleic acids encoding same
WO2002016599A3 (en) Proteins and nucleic acids encoding same
WO2001074856A3 (en) Wnt-7b-like polypeptides and nucleic acids encoding same
WO2002046229A3 (en) Novel proteins and nucleic acids encoding same
WO2001070978A3 (en) Polypeptides and nucleic acids encoding same
WO2001062928A3 (en) Polypeptides and nucleic acids encoding same
WO2002002625A3 (en) Novel fibroblast growth factors and nucleic acids encoding same
WO2001066747A8 (en) Proteins named fctrx and nucleic acids encoding same
WO2001061009A3 (en) Polypeptides and nucleic acids encoding same
WO2001044473A3 (en) Polypeptides and nucleic acids encoding same
WO2001036638A8 (en) Polypeptides and nucleic acids encoding same
WO2001068851A3 (en) Polypeptides and nucleic acids encoding same
WO2002036632A3 (en) Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides
WO2001023561A3 (en) Novel polynucleotides encoding proteins containing thrombospondin type 1 repeats
WO2003040345A3 (en) Type 2 cytokine receptor and nucleic acids encoding same
WO2001032874A3 (en) Polypeptides and nucleic acids encoding same
WO2001036635A3 (en) Neurite outgrowth-promoting factor homologue and nucleic acids encoding same

Legal Events

Date Code Title Description
CFP Corrected version of a pamphlet front page
121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP